Dr. Stephen Levine Reflects on 40 Years in Gender Medicine. - Original Rebels Series (#21
Dr. Stephen Levine co-founded one of America's first gender clinics in 1974 and chaired the WPATH Standards of Care committee that has shaped clinical practice across Europe for decades. In this conversation he traces how organised psychiatry moved from genuine inquiry to enforced consensus — booing instead of peer review, advocacy instead of evidence. For European clinicians navigating post-Cass reforms, the suspension of puberty blockers in Sweden and Finland, and reassessments underway in the Netherlands and Germany, Levine's insider account of institutional capture offers an indispensable historical frame.
Dr. Stephen Levine has spent half a century doing what most of his colleagues eventually stopped doing: asking questions. A Clinical Professor of Psychiatry at Case Western Reserve University, he co-founded one of the United States' first gender identity clinics in 1974, and later chaired the fifth Standards of Care committee for what would become the World Professional Association for Transgender Health. Those credentials matter because WPATH's Standards of Care have been adopted, adapted, and deferred to by clinicians across Europe — from Amsterdam to Helsinki — for decades. In this episode Levine traces the arc of a discipline that began with genuine clinical uncertainty and ended — at least in its organised institutional form — with something closer to an enforced orthodoxy. He describes attending WPATH conferences where dissenting views were met with booing rather than counterargument, and where professional peer review gave way to advocacy. He left the organisation in 2002, long before the scale of harm to young patients became a public controversy, which is precisely what makes his account so historically significant. One of the sharpest threads in the conversation is the myth of the two percent regret rate — a figure that circulated widely through European clinical and policy circles for years, lending false certainty to what was always an evidence-thin field. Levine argues that the honest answer to many of the foundational questions in gender medicine is simply that we do not know, and that this uncertainty was systematically suppressed rather than acknowledged. His account of how rapidly diagnosing gender dysphoria became normalised at the expense of proper psychiatric assessment will resonate with clinicians who have watched the same pattern unfold in their own countries. For European audiences, the episode arrives at a moment of reckoning. Sweden and Finland suspended puberty blockers for minors years before the Cass Review reached its conclusions in England. The Netherlands, whose protocols provided the original clinical template for paediatric gender medicine worldwide, is reassessing its own evidence base. In France and Germany, professional and parliamentary debates about the appropriate age and conditions for medical intervention are becoming harder to sidestep. Levine's long view — shaped by decades of treating patients rather than advocating for a political position — adds necessary historical depth to these national conversations. The episode also explores the psychological and relational dimensions of gender dysphoria, including the relationship between paraphilias and barriers to intimacy, territory that remains almost entirely absent from mainstream clinical training in Europe today. Levine is consistent in his insistence that curiosity, not compliance, is the appropriate response to a person in distress. That insistence, increasingly rare in professional circles, is what cost him his standing in the field he helped build — and what makes his perspective so valuable now.
